Elevated cardio-ankle vascular index (CAVI ≥ 8.0) was significantly associated with an increased risk of renal function decline (HR 1.188) and demonstrated the highest discriminatory power among the evaluated arterial stiffness parameters.
Cohort (n=27,864)
Do baseline arterial stiffness parameters (CAVI, haPWV, CAVI0) predict renal function decline in a general population without baseline renal impairment?
Increased arterial stiffness, particularly as measured by the cardio-ankle vascular index (CAVI), is a significant and independent predictor of renal function decline in the general population.
Hazard Ratio: 1.188 (95% CI 1.043–1.353)
p-value: p=<0.05
OBJECTIVE: The relative usefulness of arterial stiffness parameters on renal function remains controversial. This study aimed to compare the predictive ability of three arterial stiffness parameters at baseline; cardio-ankle vascular index (CAVI), heart-ankle pulse wave velocity (haPWV) and CAVI 0 , a variant of CAVI that theoretically excludes dependence on blood pressure, for renal function decline in Japanese general population. METHODS: A total of 27 864 Japanese urban residents without renal impairment at baseline who participated in two to eight consecutive (mean 3.5 ± 1.7 times) annual health examinations were studied. RESULTS: During the study period, 6.6% of participants developed renal function decline (estimated glomerular filtration rate <60 ml/min per 1.73 m 2 ), all of whom had relatively high values in all arterial stiffness parameters. In receiver-operating characteristic curve analysis, the discriminatory power for renal function decline showed a decreasing trend of CAVI to haPWV to CAVI 0 (C-statistic: 0.740 vs. 0.734 vs. 0.726). The cut-offs were CAVI 8.0, haPWV 7.23 and CAVI 0 11.6. In Cox-proportional hazards analysis for increase of each parameter above cut-off or by 1 standard deviation (SD) adjusted for two models of confounders, only CAVI always contributed significantly to renal function decline. Restricted cubic spline regression analysis suggested that CAVI most accurately reflected the risk of renal function decline. CONCLUSION: Increase in arterial stiffness parameters, especially CAVI, may represent a major modifiable risk factor for renal function decline in the general population. Further research is needed to examine whether CAVI-lowering interventions contribute to the prevention of chronic kidney disease.
Nagayama et al. (Fri,) conducted a cohort in Renal function decline (n=27,864). Cardio-ankle vascular index (CAVI) ≥ 8.0 vs. CAVI < 8.0 was evaluated on Renal function decline (eGFR < 60 ml/min per 1.73 m2) (HR 1.188, 95% CI 1.043-1.353, p=<0.05). Elevated cardio-ankle vascular index (CAVI ≥ 8.0) was significantly associated with an increased risk of renal function decline (HR 1.188) and demonstrated the highest discriminatory power among the evaluated arterial stiffness parameters.